Shingles and Appetite Changes: Understanding Nausea & Loss of Appetite

Herpes zoster (shingles) reactivation causes inflammation of dorsal root ganglia and cutaneous nerves. Anorexia and nausea are common systemic symptoms.

Mechanisms

  • Cytokine release: IL-1, TNF-α, IL-6 from viral inflammation act on hypothalamus → anorexia, fever, malaise.
  • Visceral involvement: Thoracic dermatomes (T5–T10) innervate stomach, liver, gallbladder, pancreas. Neuritis can cause referred nausea, epigastric pain, ileus.
  • Pain-stress axis: Severe pain → sympathetic activation → gastric stasis, nausea.
  • Medication side effects: Antivirals (valacyclovir – nausea), opioids, gabapentinoids.

Clinical Presentation

  • Prodrome (1–5 days): pain, paresthesia, headache, malaise, anorexia – before rash.
  • Active: dermatomal vesicular rash + pain (burning, lancinating, allodynia).
  • Anorexia/nausea may persist throughout acute phase (2–4 weeks).

Management

  1. Antivirals (start ≤72h rash): Valacyclovir 1g TID ×7d (preferred), famciclovir 500mg TID, acyclovir 800mg 5x/day. Reduces severity, duration, PHN risk.
  2. Pain control: NSAIDs/acetaminophen → gabapentin/pregabalin → opioids (short-term) ± TCAs/SNRIs for neuropathic component.
  3. Nausea: Ondansetron, metoclopramide, prochlorperazine; small frequent meals, ginger, hydration.
  4. Corticosteroids: Controversial; may add modest benefit in severe cases (prednisone taper) but risks in elderly/immunocompromised.

Complications

  • Postherpetic neuralgia (PHN): pain >90 days after rash onset (10–18% risk, ↑ with age).
  • Herpes zoster ophthalmicus (V1) → vision loss.
  • Ramsay Hunt (geniculate ganglion) → facial palsy, hearing loss.
  • Disseminated (immunocompromised) → visceral involvement (hepatitis, pneumonitis, encephalitis).

Vaccination: Shingrix (RZV) 2 doses ≥50y or ≥19y immunocompromised – >90% effective.

Eating Disorders - Related Articles